Inhibiting an enzyme may cure Alzheimer’s

Israel’s ProteKt Therapeutics is developing a treatment for early stage Alzheimer’s disease. It inhibits the PKR enzyme that is over-expressed in Alzheimer’s patients and may slow or even reverse the progress of the disease. It also has potential for ALS, Huntington and Parkinson’s.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *